Vical to Provide Company Update at BIO Investor Forum Conference

GlobeNewswire 13-Oct-2017 4:05 PM

SAN DIEGO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 11:30 a.m. PT on Wednesday, October 18, at the BIO Investor Forum Conference (San Francisco October 17-18). A webcast of the companys presentation will be available live through the Events & Presentations page in the Investors section of the Vical website at

About Vical Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at

Contact: Tony Ramos(858)

Image for Press Release 515490

Source: Vical Incorporated

Wait, Before You Leave...

Receive Anticipated Price Moves into Earnings

Enter your email address below to receive FREE daily information about expected earnings moves and upcoming earnings.
Market Chameleon